Triciribine
Triciribine is a synthetic tricyclic nucleoside that has been studied for its potential use as an anti-cancer agent. It is known for its ability to inhibit Akt (also known as Protein Kinase B), which plays a crucial role in various cellular processes including glucose metabolism, apoptosis, cell proliferation, transcription, and cell migration.
Chemical Structure and Properties
Triciribine, also known as API-2, has a chemical structure that includes a tricyclic ring system. Its molecular formula is C13H14N4O3, and it has a molecular weight of 274.28 g/mol. The compound is characterized by its ability to interfere with the phosphorylation of Akt, thereby inhibiting its activity.
Mechanism of Action
Triciribine functions primarily by inhibiting the phosphorylation of Akt, a serine/threonine-specific protein kinase. Akt is a key component of the PI3K/AKT/mTOR pathway, which is involved in cell survival and growth. By inhibiting Akt, Triciribine can induce apoptosis in cancer cells and inhibit tumor growth. This makes it a promising candidate for cancer therapy, particularly in cancers where the Akt pathway is dysregulated.
Clinical Applications
Triciribine has been investigated in various clinical trials for its efficacy in treating different types of cancer, including breast cancer, prostate cancer, and melanoma. Although it has shown potential in preclinical studies, its clinical development has faced challenges, including issues related to its bioavailability and toxicity.
Research and Development
Ongoing research is focused on improving the delivery and efficacy of Triciribine. Strategies include the development of Triciribine derivatives and combination therapies with other anti-cancer agents. Researchers are also exploring its potential use in combination with chemotherapy and radiotherapy to enhance its anti-tumor effects.
Related Pages
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD